SVRA

NASDAQ · Biotechnology

Savara Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.12

-0.12 (-2.29%)

As of May 9, 1:37 AM ET ·

Day Range $5.07 — $5.27

52W Range $1.89 — $7.01

Open$5.19

Previous Close$5.24

Day High$5.27

Day Low$5.07

52W High$7.01

52W Low$1.89

Volume—

Avg Volume1.14M

Market Cap1.06B

P/E Ratio—

EPS$-0.53

SectorBiotechnology

Analyst Ratings

Strong Buy

14 analysts

13 Buy 1 Hold 0 Sell

Price Target +1,129.3% upside

Current
$5.12

Target
$62.94

$52.50 $62.94 avg $80.97

Key Financials

	FY 2025	FY 2024	FY 2023
Revenue	135.25M	127.87M	115.53M
Net Income	19.67M	13.91M	14.59M
Profit Margin	14.5%	10.9%	12.6%
EBITDA	27.67M	31.26M	23.85M
Free Cash Flow	12.49M	17.00M	15.12M
Rev Growth	+10.1%	-5.7%	+15.6%
Debt/Equity	0.38	0.46	0.53

Biotechnology Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
ABBV	Abbvie Inc	$201.55	-0.57%	88.1	372.29B
AMGN	Amgen Inc	$331.70	+0.79%	22.7	176.88B
GILD	Gilead Sciences Inc	$131.33	-2.04%	19.3	163.92B
VRTX	Vertex Pharmaceuticals Inc	$429.82	+1.13%	27.7	109.50B
REGN	Regeneron Pharmaceuticals	$714.89	+0.82%	16.5	74.30B
ALNY	Alnylam Pharmaceuticals Inc	$295.05	-0.29%	130.4	40.90B

Next Earnings

May 11, 2026

After Market Close

0 days away

EPS Est: $-0.14

SVRA News

No news for SVRA yet

Quick Stats

Market Cap1.06B

P/E Ratio—

EPS$-0.53

Volume—

SectorBiotechnology